Kennesaw State University

DigitalCommons@Kennesaw State University
Faculty Publications

5-2011

Characterization of Ceriporiopsis subvermispora
Bicupin Oxalate Oxidase Expressed in Pichia
pastoris
Patricia Moussatche
University of Florida

Alexander Angerhofer
University of Florida

Witcha Imaram
University of Florida

Eric Hoffer
Kennesaw State University

Kelsey Uberto
Kennesaw State University
See next page for additional authors

Follow this and additional works at: http://digitalcommons.kennesaw.edu/facpubs
Part of the Biochemistry Commons, and the Chemistry Commons
Recommended Citation
Moussatche P, Angerhofer A, Imaram W, Hoffer E, Uberto K, Brooks C, Bruce C, Sledge D, Richards NGJ, Moomaw EW. 2011.
Characterization of ceriporiopsis subvermispora bicupin oxalate oxidase expressed in pichia pastoris. Arch Biochem Biophys
509(1):100-7.

This Article is brought to you for free and open access by DigitalCommons@Kennesaw State University. It has been accepted for inclusion in Faculty
Publications by an authorized administrator of DigitalCommons@Kennesaw State University. For more information, please contact
digitalcommons@kennesaw.edu.

Authors

Patricia Moussatche, Alexander Angerhofer, Witcha Imaram, Eric Hoffer, Kelsey Uberto, Christopher Brooks,
Crystal Bruce, Daniel Sledge, Nigel G. J. Richards, and Ellen W. Moomaw

This article is available at DigitalCommons@Kennesaw State University: http://digitalcommons.kennesaw.edu/facpubs/1313

NIH Public Access
Author Manuscript
Arch Biochem Biophys. Author manuscript; available in PMC 2012 May 1.

NIH-PA Author Manuscript

Published in final edited form as:
Arch Biochem Biophys. 2011 May 1; 509(1): 100–107. doi:10.1016/j.abb.2011.02.022.

Characterization of Ceriporiopsis subvermispora Bicupin
Oxalate Oxidase Expressed In Pichia pastoris
Patricia Moussatchea,1, Alexander Angerhofera, Witcha Imarama, Eric Hofferc, Kelsey
Ubertoc, Christopher Brooksb, Crystal Bruceb, Daniel Sledgeb, Nigel G. J. Richardsa, and
Ellen W. Moomawb,c,*
aDepartment of Chemistry, University of Florida, P.O. Box 117200, Gainesville, FL 32611-7200
bDepartment

of Chemistry, Gainesville State College, 3820 Mundy Mill Road, Oakwood, GA

30566-3414
cDepartment

of Chemistry and Biochemistry, Kennesaw State University, 1000 Chastain Road,
Kennesaw, GA 30144-5588

NIH-PA Author Manuscript

Abstract
Oxalate oxidase (E.C. 1.2.3.4) catalyzes the oxygen-dependent oxidation of oxalate to carbon
dioxide in a reaction that is coupled with the formation of hydrogen peroxide. Although there is
currently no structural information available for oxalate oxidase from Ceriporiopsis
subvermispora (CsOxOx), sequence data and homology modeling indicate that it is the first
manganese-containing bicupin enzyme identified that catalyzes this reaction. Interestingly,
CsOxOx shares greatest sequence homology with bicupin microbial oxalate decarboxylases
(OxDC). We show that CsOxOx activity directly correlates with Mn content and other metals do
not appear to be able to support catalysis. EPR spectra indicate that the Mn is present as Mn(II),
and are consistent with the coordination environment expected from homology modeling with
known X-ray crystal structures of OxDC from Bacillus subtilis. EPR spin-trapping experiments
support the existence of an oxalate-derived radical species formed during turnover. Acetate and a
number of other small molecule carboxylic acids are competitive inhibitors for oxalate in the
CsOxOx catalyzed reaction. The pH dependence of this reaction suggests that the dominant
contribution to catalysis comes from the monoprotonated form of oxalate binding to a form of the
enzyme in which an active site carboxylic acid residue must be unprotonated.
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Introduction
Commercial applications of oxalate degrading enzymes include their use in clinical assays
of oxalate in blood and urine [1,2], the production of transgenic plants as a means of

© 2011 Elsevier Inc. All rights reserved
*
Corresponding author: phone (678) 797-2258, FAX (770) 302-4357, emoomaw@kennesaw.edu.
1Present address: Foundation for Applied Molecular Evolution, P.O. Box 13174, Gainesville, FL 32604.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Moussatche et al.

Page 2

NIH-PA Author Manuscript

protection against pathogens and to reduce the amount of oxalate present [3,4], the
bioremediation of oxalate waste, the production of hydrogen peroxide, and pulping in the
paper industry [3,5–7]. Oxalate oxidase (OxOx) catalyzes the difficult carbon-carbon bond
cleavage of oxalate to yield carbon dioxide and hydrogen peroxide [8–10] (Scheme 1).
OxOx was first described in a study of wheat flour and has since been found in numerous
microbes and plants [11]. OxOx activity has been detected in barley [8,12,13], beet [14,15],
sorghum [16,17], maize, oats, rice, and rye [10,18]. Hydrogen peroxide formation is
believed to serve as a defense mechanism against infection by pathogens and to contribute to
cell wall crosslinking in these species. The best characterized oxalate oxidases are from
barley and wheat. These plant enzymes contain a single β-barrel fold characteristic to the
cupin superfamily of proteins and are therefore classified as monocupins.
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Fungal OxOx activity was first reported in Ceriporiopsis subvermispora, a white rot
basidiomycete fungus able to degrade lignin, in 1999 [19]. In 2005, the gene encoding
CsOxOx was cloned and sequenced [20]. Although there is currently no structural
information available for oxalate oxidase from Ceriporiopsis subvermispora (CsOxOx),
sequence data and homology modeling indicate that it is the first manganese-containing
bicupin enzyme identified that catalyzes this reaction. Interestingly, CsOxOx shares greatest
sequence homology with bicupin microbial oxalate decarboxylases (OxDC). OxDC
catalyzes the carbon-carbon bond cleavage of oxalate to yield carbon dioxide and formate in
a reaction in which there is no net oxidation or reduction [20]. UV-visible spectroscopy, spin
trapping studies, and structural studies of barley oxalate oxidase have led to a proposed
mechanism that involves the binding of oxalate directly to Mn(II), the formation of Mn(III),
and a radical intermediate species (Scheme 2) [9,10,21,22]. The first step after oxalate and
dioxygen bind to the Mn(II) ion is a reversible proton-coupled electron transfer that
facilitates decarboxylation to yield a manganese-bound formyl radical. In OxDC an active
site general acid (Glu162 in the N-terminal domain or alternatively, Glu333 in the Cterminal domain) is proposed to protonate the manganese-bound formyl radical and formate
is released.
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Initial characterization of the native CsOxOx was done by Aguilar et al., who purified 0.38
mg of native enzyme from 30 g of mycelium. The pH optimum reported for catalysis was
3.5, the specific activity 10.4 U/mg, the Km 0.1 mM. Histochemical studies of mycelium
slices showed reaction products in both membrane vesicles connected to the outer
membrane and peroxisome-like structures [19]. The fact that enzyme activity could be
localized to multivesicular membrane bodies suggests that the enzyme is transported and
secreted to the periplasmic space. The role of OxOx in C. subvermispora is still not well
understood, but it has been proposed that CsOxOx may provide H2O2 to enable manganese
peroxidase to oxidize extracellular Mn(II) to Mn(III). Mn(III), a diffusible and strong
oxidant, is thought to facilitate lignin degradation [23].
Previous attempts to purify recombinant CsOxOx were not successful. Recombinant
CsOxOx could only be expressed in E. coli with the assistance of co-transformed DnaK and
DnaJ chaperone proteins, and attempts to purify the recombinant enzyme resulted in protein
of only 40% purity, which precluded characterization of this novel enzyme [20]. We
describe herein the first purification to homogeneity and characterization of recombinant
bicupin oxalate oxidase. By characterizing oxalate oxidase from Ceriporiopsis
subvermispora we can enhance the understanding of how subtle structural changes effect
remarkable functional variation in evolutionarily related proteins.
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Materials and methods
Materials
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Unless otherwise stated, all chemicals and reagents were purchased from Sigma-Aldrich and
were of the highest available purity. All DNA primers were obtained from Integrated DNA
Technologies, Inc., and DNA sequencing was performed by the core facility in the
Interdisciplinary Center for Biotechnology Research (ICBR) at the University of Florida.
Restriction enzymes and other molecular biology reagents were purchased from New
England Biolabs.
Expression and purification of recombinant bicupin oxalate oxidase
The coding sequence for CsOxOx isoform-G (GenBank accession number: AJ746412) was
amplified by PCR with primers that included an XbaI restriction site followed by a Kex2
protease cleavage site at the 5' and an XhoI restriction site at the 3'. The PCR product was
digested with XbaI and XhoI and this fragment was cloned into the pPICZαA vector
(Invitrogen) cut with the same restriction enzymes. CsOxOx was transformed into Pichia
pastoris X-33 strain using the EasyComp transformation procedure (Invitrogen).
Recombinants were screened for Zeocin resistance and the ability to grow using methanol as
a carbon source. Putative clones were screened on minimal media plates containing 40 mM
oxalate, pH 4.2. Bromophenol blue was included in the media for color selection.
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25 mL cultures of MGY media (1.34% yeast nitrogen base, 1% glycerol, 4 ×10−5 % biotin)
were inoculated with glycerol stocks of a single CsOxOx colony in a 250 mL baffled flask
and grown overnight at 28–30 °C shaking at 250 rpm until the culture reaches log phase
growth (OD600 = 2 – 6). Each of these cultures was used to inoculate 500 mL of MGY
media in a 2 liter baffled flask at 28–30 °C shaking at 250 rpm until the culture reaches log
phase growth. Cells were harvested by centrifugation at 2500 × g for five minutes at room
temperature. Induction of expression of CsOxOx was accomplished by resuspending cells to
OD600 = 1.0 in 500 mL aliquots of MM media (1.34% yeast nitrogen base, 4 ×10−5 %
biotin, 0.5% methanol) with 5 mM MnCl2 at 28–30 °C shaking at 250 rpm. Methanol was
added to 0.5 % every 24 hours for 4–5 days. Cells were removed by centrifuging 5000 × g
for 45 minutes at 15 °C. The media containing secreted CsOxOx was concentrated to
approximately 100 mL using a Biomax-30 tangential flow cassette and stirred cell
ultrafiltration (Millipore). The concentrated sample was dialyzed against 50 mM ImidazoleCl, pH 7.0 (buffer A) and applied to a DEAE-Sepharose Fast Flow column (2.5 × 25 cm)
equilibrated with buffer A. Elution was performed using a 500 mL linear gradient from
buffer A to buffer A containing 1 M NaCl. Fractions containing OxOx activity were pooled,
and solid (NH4)2SO4 added to a final concentration of 1.7 M. The resulting solution was
applied to a butyl-Sepharose Hi-Performance column (2.5 × 18 cm) (GE Healthcare,
Piscataway, NJ) equilibrated with 50 mM Imidazole-Cl, pH 7.0, containing 1.7 M
(NH4)2SO4 (buffer B). Bound proteins were eluted using a 500 mL linear gradient from
buffer B to buffer A, and fractions containing purified CsOxOx were pooled, and
concentrated by stirred cell ultrafiltration (Millipore) to a final volume of 10 mL before
being exhaustively dialyzed against 25 mM Imidazole-Cl, pH 7.0. The dialyzed enzyme was
then concentrated to approximately 10 mg/mL, and stored in aliquots at −80 °C. Expression
and purification of heterologously expressed CsOxOx was monitored by SDS-PAGE carried
out using a Mini Protean chamber system (Bio-Rad). Gels were stained for proteins using
Coomassie stain and for carbohydrates using a Gel-Code Glycoprotein Staining Kit (Pierce).
Protein concentrations were determined using a modified Lowry assay (Pierce, Rockford,
IL) for which standard curves were constructed with bovine serum albumin [24].
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Steady-state kinetic assays
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The level of oxalate oxidase activity was determined using a continuous assay in which
H2O2 production is coupled to the horseradish peroxidase (HRP) catalyzed oxidation of 2,2'azinobis-(3-ethylbenzthiazoline-6-sulphonic acid) (ABTS) [13]. Reaction mixtures
contained 25 U HRP, 5 mM ABTS, 50 mM potassium oxalate, CsOxOx (at concentrations
up to 0.050 mg/mL) dissolved in 50 mM sodium acetate, sodium succinate, or sodium
citrate, pH 4.0 (total volume 1.0 mL). Assays were monitored at 650 nm and an extinction
coefficient of 10,000 M−1 cm−1 for the ABTS radical product was assumed in these
experiments. Control samples omitted HRP in order to distinguish between H2O2 production
and any oxalate-dependent dye oxidation activity by CsOxOx. Measurements were made at
specific substrate and enzyme concentrations in duplicate, and data were analyzed to obtain
the values of Vmax and Vmax/Km by standard computer-based methods [25]. Assay mixtures
for the construction of the pH profile with acetate present contained a final concentration of
50 mM glycine, 50 mM acetate, and 50 mM MES.
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The continuous coupled assay described above (using succinate buffer) was used to measure
the inhibition of acetate, malonate, malate, glycolate, glyoxylate, and pyruvate. The mode of
inhibition for all compounds tested was determined by measuring the enzyme velocity at a
variety of substrate concentrations in the presence and absence of the possible inhibitor. All
of the compounds that showed inhibition diminished enzyme velocity at low concentrations
of substrate but the velocity reached uninhibited maximal levels at high concentrations of
substrate. Since, therefore, the compounds were competitive inhibitors, the inhibition
constants were determined by observing the apparent Km (Km,obs) at two concentrations of
inhibitor and calculating Ki by equation 1 which defines Ki as the inhibitor concentration
that doubles the apparent Km of the competing substrate.

(1)

The pH dependence of Vmax/Km was determined by measuring the initial rate at varying
concentrations of oxalate. Assay mixtures in these experiments each contained a final
concentration of 50 mM glycine, 50 mM succinate, and 50 mM MES adjusted to specific pH
values. Substrate solutions were pH adjusted also. The log(Vmax) and log(Vmax/Km) were
plotted versus pH, and the data were fit to equations 2 and 3 using the program GraphPad
Prism.
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(2)

(3)

In addition to measuring the rate at which hydrogen peroxide was produced by the enzymecatalyzed oxidation of oxalate, we determined the level of oxalate decarboxylase activity of
CsOxOx. Assay mixtures consisted of 50 mM NaOAc, pH 4.2, 0.2% Triton X-100, 0.5 mM
o-phenylenediamine, 1–50 mM potassium oxalate, and CsOxOx (50 μM) (100 μL total
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volume). Reactions were initiated by the addition of substrate, incubated at ambient
temperature (21–23°C), and quenched by the addition of 1 N NaOH (10 μL). The amount of
formate produced was determined by an end-point assay [26] consisting of 50 mM
potassium phosphate, pH 7.8, 0.09 mM NAD+, and 0.4–1.0 U/mg of formate dehydrogenase
(1 mL final volume). The absorbance at 340 nm was measured after overnight incubation at
37 °C, and formate was quantified by comparison to a standard curve generated by spiking
pre-quenched assay mixtures with known amounts of sodium formate.
Determination of Mn content
The metal content of CsOxOx samples was quantified at the University of Wisconsin Soil
and Plant Analysis Laboratory on the basis of inductively-coupled plasma mass
spectroscopy (ICPMS) [27] and by Flame Atomic Absorption Spectroscopy (FAAS) [28]
using a Varian SpectrAA-55 and comparing measurements to a standard curve constructed
using dilutions of a standard solution of MnCl2 (Fisher). To prepare samples and blanks for
determination of metal content, divalent cations were removed from the final enzyme
storage buffer by passing through a 1.5 × 16 cm column containing Chelex 100 (Bio-Rad) in
the Na+ form. Purified protein samples were exchanged into the resulting buffer by washing
2.5 mg samples three times with 10-fold volumes of the “scrubbed” buffer in Centricon or
Centriprep 30 (Amicon) concentrators [29]. The final filtrates recovered were used as
blanks, which possessed insignificant metal content.
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Preparation of Apoenzyme
This procedure was modified from that used to prepare manganese-deficient oxalate
decarboxylase [30]. Recombinant CsOxOx was dialyzed against 3.5 M guanidinium
hydrochloride (GuHCl), 20 mM Tris-HCl, and 10 mM EDTA, pH 3.1, for 8 h at 4 °C. A
second round of dialysis against 2.5 M GuHCl, 20 mM Tris-HCl, and 10 mM EDTA, pH
7.0, was performed, and excess EDTA removed in a third dialysis against 2.5 M GuHCl
containing 20 mM Tris-HCl, pH 7.0 again for 8 h at 4 °C. CsOxOx was then re-folded by
dialysis against 25 mM Imidazole-Cl, pH 7.0, over 8 h at 4 °C, to yield a Mn-deficient form
of OxDC (“apoenzyme”) that exhibited no catalytic activity when incubated with oxalate.
EPR spectroscopy
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EPR spectra were determined using CsOxOx (16 mg/mL) in 25 mM Imidazole-Cl, pH 7.0
(100 μL total volume). For low temperature EPR spectra the samples were taken as prepared
and added to a 3×4 mm (IDxOD) quartz tube (approx. 100 μL per sample) then quickly
frozen in pre-cooled isopentane. A test tube of liquid isopentane was inserted into a dewar
filled with liquid nitrogen. After 1 to 2 min as the isopentane started to freeze at the walls of
the test tube the EPR sample tube was plunged into the cold isopentane which resulted in
immediate freezing of the sample inside. When preparing samples at lower pH in acetate
buffer a 1.0 M acetate buffer stock solution was prepared and adjusted to pH 4.0 using HCl.
For oxalate addition we prepared a 0.5 M oxalic acid solution using KOH to adjust the pH to
4.0. 15 μL of the acetate buffer stock solution was added to 150 μL of CsOxOx enzyme
solution for a sample at low pH (measured as 4.6) and a final acetate concentration of about
91 mM. To this sample 18 μL of the oxalate stock solution was added for a final oxalate
concentration of about 50 mM. The sample was then frozen as described above in precooled isopentane after a reaction time of about 5 seconds. EPR experiments at cryogenic
temperatures were conducted on a Bruker Elexsys E580 spectrometer equipped with an
Oxford ESR900 helium cryostat. Pre-frozen samples were inserted into the pre-cooled
cryostat. The instrumental settings for the spectra shown here were: sweep width, 7,000 G;
number of data points/sweep, 2048; microwave frequency, 9.454 GHz; microwave power,
630 μW; modulation amplitude, 20 G; modulation frequency, 100 kHz; receiver gain, 70 dB;
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time constant, 40 ms; conversion time, 40 ms, temperature, 5 K, and each spectrum was the
average of four field sweeps.
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EPR spin-trapping experiments
The reaction mixtures, conducted in 0.2 M potassium acetate buffer pH 4.1, contained: 100
mM oxalate (or 1,2-13C-oxalate), 100 mM KCl, 20 mM PBN or 50 mM DMPO, and 50 μM
CsOxOx. A small aliquot of the reaction mixture was transferred into a quartz capillary of
approximately 1×3 mm ID×OD for EPR measurement. The EPR spectrum was recorded at
room temperature, using a Bruker Elexsys E580 spectrometer, employing the high-Q cavity
(ER 4123SHQE). EPR parameters were typically: 100 KHz modulation frequency, 1 G
modulation amplitude, 20.18 ms time constant, 81.92 ms conversion time/point, 70 G sweep
width, 9.87 GHz microwave frequency, and 2 mW microwave power.

Results and discussion
Enzyme expression and purification
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Previous work with the native CsOxOx suggested that this enzyme is secreted. We
considered this an important aspect that should be taken into account in the expression of the
recombinant enzyme and might explain why previous attempts to express and purify this
protein in E. coli failed. In order to produce recombinant secreted protein, CsOxOx was
amplified by PCR with an engineered Kex2 protease cleavage site at the 5' and this fragment
was cloned into the pPICZαA vector (Invitrogen) as described in Materials and Methods.
This cloning strategy led to the translation of untagged, full-length CsOxOx preceded by the
α-mating factor signal secretion sequence. The engineered Kex2 protease cleavage site
ensures that the α-factor signal sequence is removed from the expressed recombinant
CsOxOx. CsOxOx was transformed into Pichia pastoris X-33 strain and recombinant
colonies were screened for Zeocin resistance and the ability to grow using methanol as a
carbon source.
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In order to ensure that the selected colonies were expressing functional recombinant enzyme
that retained OxOx activity, we screened candidate colonies on minimal media plates
containing 40 mM oxalate, pH 4.2 and bromophenol blue. Changes in pH affect the color of
the dye, which allowed us to monitor oxalate degradation. Colonies grown under noninducing conditions presented a yellow tint (Figure 1A). When methanol was used to induce
recombinant protein expression (Figure 1B), colonies expressing functional CsOxOx (first
row) were able to degrade oxalate and presented a blue tint due to the rise in pH, while
empty vector (second row) and untransformed control (third row) did not show blue color.
The Mut− strain KM71H is unable to grow in the presence of methanol; it is used as a
control for the presence of methanol in the plates and as a negative control for the Mut+
mutation. The blue color noticeable in the fourth row (Figure 1B) is due to changes in pH
resulting from cell death. Therefore, viable, recombinant colonies that were able to produce
blue color on oxalate selection plates were selected for large scale protein expression and
purification.
Under methanol-induced expression, CsOxOx was secreted into the growth media as a
soluble, functional enzyme. CsOxOx was purified from the expression media as described in
Materials and Methods. Approximately 10 mg of purified CsOxOx was obtained from 2.5 L
of growth medium (Table 1). The majority of the purification comes from the hydrophobic
interaction chromatography step (32-fold). Gel analysis of both the DEAE pools and butylsepharose pools indicate each is purified to greater than 90% homogeneity (Fig. 2). This
suggests that the butyl-sepharose column is separating inactive from active enzyme given
the increase in activity after the latter step.
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The recombinant enzyme is highly glycosylated, as shown by carbohydrate staining (Fig.2).
This is consistent with the presence of three possible N-glycosylation sites previously
identified in its sequence [20]. Due to its carbohydrate content, the purified protein runs as a
66 kD protein. The calculated molecular weight of CsOxOx based on amino acid sequence
is 45 kD implying that carbohydrates make up approximately 30% of its mass. This high
level of glycosylation makes staining with Coomassie a challenge. Gels require long stain
times and will eventually destain completely if left in destain solution for long periods of
time. Hence, visualizing the Coomassie stained CsOxOx band is a balance between staining
and destaining.
Competitive inhibition of CsOxOx by acetate and other carboxylic acids
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As shown in Fig.3, the pH optimum of CsOxOx is 4.0. Steady-state experiments carried out
in acetate buffer, pH 4.0 yielded a Vmax value of 21.2 U/mg that compares very favorably
with the value obtained previously for the native enzyme [19]. The Km for oxalate,
determined in acetate buffer, was 14.9 mM, which was, however, significantly larger than
the 0.1 mM value reported for the native enzyme. Table 2 shows that the steady-state kinetic
parameters are very sensitive to the buffer in which the assay is performed. When succinate
buffer, pH 4.0 is used the Km for oxalate is 1.5 mM and when citrate buffer, pH 4.0 is used
the Km is 0.1 mM. The apparent Km value of 0.1 mM in citrate suggests that succinate might
be a competitive inhibitor. The Vmax in citrate is, however, reduced and the addition of
succinate increases the activity of the citrate inhibited enzyme. This suggests that citrate is a
weak uncompetitive inhibitor of CsOxOx. Citrate inhibited enzyme still turns over at about
40% of the uninhibited rate. Succinate appears to displace citrate without inhibiting the
enzyme. There is no evidence for succinate inhibition. Since the pH optimum for this
enzyme catalyzed reaction is 4.0, it is customary (and necessary) to use carboxylic acids as
buffers at this pH. We have determined that acetate and a number of other carboxylic acids
(malonate, malate, glycolate, glyoxylate, and pyruvate) diminished enzyme velocity at low
concentrations of substrate but the velocity reached uninhibited maximal levels at high
concentrations of substrate and are, therefore, competitive inhibitors. This is consistent with
the structural similarities between acetate and oxalate. The inhibition constants are given in
Table 3. None of the inhibitors tested served as alternative substrates.
OxDC activity assay of CsOxOx
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Previously characterized OxDC's and OxOx's possess between 2% and 4% of the other
respective activity [20,31]. An E162Q mutant of OxDC exhibited an approximately 200-fold
decrease in OxDC activity with an approximately 10-fold increase in OxOx activity [32]. A
theoretical study suggested that the intrinsic reactivity of the N-terminal Mn-binding site of
OxDC is to oxidize oxalate and that decarboxylation is a result of the protein environment
modulating this reactivity through the addition of a proton donor as well as through
electrostatic changes [33]. Burrell et al. have demonstrated that the decarboxylase can be
converted to an oxidase by mutating amino acids of a flexible lid that, when in the “closed”
conformation, seals the Mn-binding site from bulk solvent [22]. Mutations of this lid, which
contains Glu162, have resulted in specificity switches of up to 282 000 (SEN161-3DSS),
275 000 (SENS161-4DSSN), and 225 000 (SENS161-4DASN). The structure of the
SENS161-4DSSN mutant showed that the C-terminal Mn-binding site was not affected.
This group's sequence information of oxalate oxidase from Ceriporiopsis subvermispora
played a critical role in the recognition that lid peptide sequences can control reaction
specificity. It was, therefore, of interest to determine the oxalate decarboxylase activity of
recombinant CsOxOx. Recombinant CsOxOx possesses less than 0.1% OxDC activity (data
not shown) which is consistent with the observation that the enzyme purified from C.
subermispora possesses less than 0.6% OxDC activity [20].
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Manganese dependency of CsOxOx
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Enzymes in the cupin superfamily appear to be able to employ a variety of metals in
catalysis [34–36]. Characterizing the manganese dependence of CsOxOx is significant to
place this enzyme in the context of other oxalate degrading enzymes and that of other cupin
proteins. Of the 54 unique cupin (double stranded beta helix) proteins with structures
deposited in the database 24 contain no metal, 16 contain Fe, 4 contain Mn, 4 contain Zn, 3
contain Ni, 2 Cu and 1 Hg. Two methods were used to determine the manganese content of
three independently purified samples: Flame Atomic Absorption Spectroscopy (FAAS) and
Inductively-Coupled Plasma Mass Spectroscopy (ICP-MS). As shown in Table 4, the two
methods showed comparable results, and manganese levels obtained were between 0.1 and
0.4 mole Mn/mole enzyme. The specific activities of these individual preparations show a
direct correlation with manganese content. The specific activity of our preparations is
limited by the amount of manganese that we can incorporate using the Pichia expression
system.
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To test whether or not other metal ions were able to support catalysis, we prepared “apoCsOxOx” by unfolding it in the presence of EDTA and refolding it in metal-free buffer in a
procedure previously used for oxalate decarboxylase [30]. The apo-CsOxOx enzyme does
not possess any oxalate oxidase activity. Incubation of the apoenzyme with a 100-fold molar
excess of MgCl2, CoCl2, CuCl2, ZnCl2, NiCl2, FeCl2 or FeCl3, individually, does not result
in the return of enzymatic activity. Incubation of the apoenzyme with a 100-fold molar
excess of MnCl2 does, however, restore activity. The return of activity by incubation with
MnCl2 required four weeks and resulted in only a small but measurable (11%) return of
activity. These experiments suggest that CsOxOx activity is highly specific for manganese.
X-band EPR spectroscopy of the manganese centers of CsOxOx
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Low temperature X-band EPR spectra of the manganese centers of CsOxOx are shown in
Fig. 4. All spectra are from the same sample subjected to different conditions. The trace
given in Fig. 4A refers to the sample in imidazole buffer at pH 7.0, as taken from the
original preparation. The Fig.4B spectrum is for the same sample that had been thawed and
then mixed with acetate buffer for a final pH of 4.6 at an acetate buffer concentration of
approximately 91 mM, as explained in “Materials and Methods.” Fig. 4C reflects the sample
after addition of oxalate and allowed to react for approximately 2 min after which it was
flash frozen in pre-cooled isopentane again. The signal to noise ratio is poor due to the low
manganese incorporation in this sample but several interesting observations can be made. In
contrast to X-band EPR spectra of oxalate decarboxylase from Bacillus subtilis [37], all
CsOxOx spectra, whether in imidazole buffer, pH 7.0 (A) or in acetate buffer, pH 4.6 (B),
appear very similar. The addition of oxalate (C) does not lead to significant spectral changes
either. In these experiments we were looking to see if a tyrosyl radical could be observed
with CsOxOx similar to what is seen in OxDC [38]. The absence of the tyrosyl radical does
not come as a surprise since it has not been observed in other oxalate oxidases but appears to
be specific to oxalate decarboxylase. The decarboxylase activity of the bicupin OxOx is
essentially zero. The addition of dithionite did not significantly increase the signal intensity
indicating that the majority of manganese in the sample is already in the Mn(II) oxidation
state (spectrum not shown). A simulation (Fig. 4D) was able to reproduce quite well the
main broad features of the spectra using a single set of magnetic parameters (D =
−3000MHz, E = 300 MHz, g = 2.00088, A = 263 MHz with 20% strain associated with the
fine structure constants D and E). The simulation, however, does not do such a good job on
the narrower features which is not surprising under the low-field conditions of Mn(II) in the
X-band. It is of course possible that a second Mn-site gives rise to some of the narrow
spectral features but the spectra are too noisy to lend any confidence in simulations with
more than one set of magnetic parameters.
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X-band spin trapping experiments
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The X-band EPR spectra of spin trapped free radicals produced during turnover by CsOxOx
is shown in Figure 5. Figure 5A shows the six-line spectrum of the PBN radical adduct
formed during turnover. The hyperfine coupling constants given in the figure legend are
consistent with those of a carboxylate radical. These data strongly support the formation of
the carbon dioxide radical anion which appears in the proposed catalytic mechanism
(Scheme 2). Figure 5B shows further splitting of the PBN adduct signal when doubly 13Clabeled oxalate is used confirming that the radical is oxalate derived. Finally, Figure 5C
shows the sextet expected of the DMPO radical adduct which has hyperfine coupling
constants consistent with a carboxylate radical. Trapping of the same species in oxalate
decarboxylase [39] is consistent with a common element between the two enzymes.
The effect of pH on the affinity of CsOxOx for oxalate
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Fig. 6B shows the Vmax/Km profile in a three component buffer system containing succinate
is asymmetrical, decreasing more rapidly on the acidic side. The slope of the acidic limb of
the Vmax/Km profile is +2 and the slope of the basic limb is −1. The Vmax/Km profile was fit
with equation 2 which assumes that monoprotonated substrate binds unprotonated enzyme
(EAH− in Fig. 6A). The fit (R2=0.95) was obtained with pKa1= 4.5, pKa2= 3.1, pKenz= 3.7,
K2= 4.0 and Vmax= 110. This is the simplest model that approximates the data and it is
possible that more pKa values are involved. These data could not be fit with the analogous
equations assuming the key species to be those defined in Fig 6A as EAH2, EA2−,
(EH+)AH2, or (EH+)AH−. We were able, however, to approximate the data equally well
(R2=0.95) by the model that assumes fully unprotonated oxalate binds protonated enzyme
((EH+)A2−) (Fig. 6A) with similar values (pKa1= 4.6, pKa2= 3.0, and pKenz= 3.6, K6= 3.7
and Vmax= 90) (fit not shown). This is not surprising since EAH− and (EH+)A2− are
formally equivalent and could represent different routes to the same species. The Vmax data
was fit using equation 3 (R2=0.96), which assumes again that monoprotonated substrate
binds unprotonated enzyme where Vmax =600, K1=12, K2=4, K3=3.2, K4=40, K5 =0.4 and
K6=0.04. Again, the experimental data could be fit equally well by the model that assumes
fully unprotonated substrate binds protonated enzyme ((EH+)A2−) (Fig. 6A) where
Vmax=30, K1=5, K2=0.09, K3=6.5, K4=28, K5=3, and K6=0.4 but could not be fit with the
analogous equations assuming the key species to be those defined in Fig 6A as EAH2, EA2,
(EH+)AH2, or (EH+)AH−.
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The simplest interpretation of these data are that two of the three pKa values required for
these models refer to oxalate (pKavalues for species free in solution are 1.3 and 4.2) and that
binding to the enzyme alters the more acidic pKa by approximately 2 units. We propose that
the third pKa value refers to an active site carboxylate residue. It is not immediately apparent
which aspartate or glutamate residue must be unprotonated to bind monoprotonated oxalate
(or protonated to bind unprotonated substrate) but it is intriguing to speculate that the
aspartate in the DASN sequence analogous to the SENS of oxalate decarboxylase shown to
be a specificity switch from decarboxylase activity to oxidase activity by Burrell et al [22]
may be implicated. We look forward to carrying out a program of site-directed mutagenesis
to test this possibility. In distinguishing between the two modes of substrate binding
suggested by the data, we propose that the simplest explanation is that monoprotonated
substrate binding to enzyme containing an unprotonated carboxylate residue near the active
site is the dominant contributor to catalysis. We base this proposal on the fact that given the
closeness of the determined pKa values, at any given pH, the fraction of substrate species
that are unprotonated while an active site residue is protonated will be very small.
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Conclusion
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We have successfully expressed CsOxOx in Pichia pastoris and purified it to homogeneity.
This recombinant enzyme is a soluble glycoprotein containing 0.2 to 0.4 mole Mn/mole of
enzyme. The specific activity of this recombinant CsOxOx is 12.8 U/mg and its pH
optimum is 4.0, which is in good agreement with the values reported for the native enzyme.
Enzyme activity directly correlates with Mn content and other metals do not appear to be
able to support catalysis. Acetate and other small molecule carboxylic acids have been
shown to be competitive inhibitors of the CsOxOx catalyzed reaction. EPR spectra indicate
that the Mn is present as Mn(II), and are consistent with the coordination environment
expected from homology modeling with known X-ray crystal structures of oxalate
decarboxylase from Bacillus subtilis. EPR spin-trapping experiments support the existence
of an oxalate-derived radical species formed during turnover. The pH dependence of the
CsOxOx catalyzed reaction suggests monoprotonated oxalate binds to a form of CsOxOx in
which an important carboxylate residue near the active site must be unprotonated for
catalysis.
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oxalate oxidase

OxDC

oxalate decarboxylase

CsOxOx

OxOx from Ceriporiopsis subvermispora

HRP

horseradish peroxidase

ABTS

2,2'-azinobis-(3-ethylbenzthiazoline-6-sulphonic acid)
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Fig. 1.
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Oxalate degradation assay. Putative clones were screened on minimal media plates
containing 40 mM oxalate, pH 4.2 and bromophenol blue was included in the media for
color selection. When colonies were grown under non-induced conditions (Figure 1A,
dextrose media), the colonies presented a yellow tint. Under induction conditions (Figure
1B, methanol media), colonies expressing CsOxOx were able to degrade oxalate and
presented a blue tint due to the raise in pH. Empty vector and untransformed control did not
show blue color. KM71H did not grow on methanol-containing plates.
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Fig. 2.
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12% SDS PAGE stained for protein and carbohydrate. Samples were applied twice (lanes 1–
4 and lanes 6–9). After electrophoresis, the gel was cut in half and one half stained with
Coomassie (lanes 1–4) and the other half stained for carbohydrate (lanes 6–9) as described
in Materials and Methods. Lanes 1 and 6: prestained molecular weight markers (97.4 kD,
66.2 kD, 45.0 kD, 31.0 kD, 21.5 kD, 14.4 kD), lanes 2 and 7 are 7 ng of concentrated media,
lanes 3 and 8 are 7 ng of DEAE pool, and lanes 4 and 9 are 7 ng butyl sepharose pool.
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Fig. 3.

pH profile of recombinant oxalate oxidase activity with acetate buffer present in the reaction
mixtures.
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Fig. 4.

X-band EPR of the Mn(II) centers of CsOxOx under several different conditions at 5 K. 4A:
CsOxOx in imidazole buffer at pH7.0, as taken from the original preparation. 4B: Same
sample, thawed and after addition of 91 mM acetate buffer pH4.0 for a final pH of 4.6. 4C:
Same sample as in the red trace, thawed and after addition of 50 mM oxalate and allowed to
further react for approximately 2 min. 4D: Spectral simulation. The instrumental settings for
the spectra were: sweep width, 7,000 G; number of data points/sweep, 2048; microwave
frequency, 9.454 GHz; microwave power, 630 μW; modulation amplitude, 20 G;
modulation frequency, 100 kHz; receiver gain, 70 dB; time constant, 40 ms; conversion
time, 40 ms, temperature, 5 K, and each spectrum was the average of four field sweeps.
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Fig. 5.
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EPR spectra of PBN and DMPO radical adducts obtained from the incubation of 100 mM
oxalate (or 1,2-13C-oxalate), 100 mM KCl, 20 mM PBN or 50 mM DMPO, and 50 μM
CsOxOx. (A) PBN-12C oxalate derived radical adduct displayed the hyperfine coupling
constants, a(N) = 15.8 G and a(H) = 4.5 G. (B) PBN-13C oxalate derived radical adduct
showed the hyperfine coupling constants, a(N) = 15.9 G, a(13C) = 11.6 G, and a(H) = 4.4 G.
(C) DMPO-12C oxalate derived radical adduct displayed the hyperfine coupling constants,
a(N) = 15.7 G and a(H) = 18.9 G.

NIH-PA Author Manuscript
Arch Biochem Biophys. Author manuscript; available in PMC 2012 May 1.

Moussatche et al.

Page 17

NIH-PA Author Manuscript
NIH-PA Author Manuscript

Fig. 6.

The effect of pH on the affinity of CsOxOx for oxalate. A: Scheme showing the dissociation
constants for the three protonation states of oxalate binding to unprotonated enzyme (E) and
protonated enzyme (EH+). B: pH dependence on kinetic parameters Vmax/Km (•) and Vmax
(▲) for the CsOxOx catalyzed reaction. The curves were generated by a fit to equations 2
and 3, respectively.
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Scheme 1.

The reaction catalyzed by Ceriporiopsis subvermispora oxalate oxidase.
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Scheme 2.

Model of free-radical mechanism for oxalate oxidation. Modified from [20].
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2300
52
50
32
1.2

Concentrated dialyzed media

DEAE pool

Butyl Sepharose pool

Concentrated CsOxOx

Vol. mL

Unconcentrated media

Fraction

8.9

9.5

147

240

268

Protein mg

114

121

132

159

188

Total Act. U

12.8

12.7

0.9

0.7

0.4

Spe. Act. U/mg
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Summary of the Purification of CsOxOx.

32.0

32.0

2.3

1.8

1.0

Purification fold

61

64

70

85

100

Yield %
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Km for oxalate varies with assay buffera.
Buffer

Km mM

Vmax U/mg

Acetate, pH 4.0

14.9 ± 0.1

21.1 ± 0.5

Succinate, pH 4.0

1.5 ± 0.1

18.2 ± 0.4

Citrate, pH 4.0

0.1 ± 0.02

8.1 ± 0.4

a

Initial velocities were measured spectrophotometrically using the coupled assay described in Material and Methods with the final concentrations
of oxalate ranging from 0.01 mM to 90 mM.
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Table 3
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Ki values for a variety of inhibitorsa.
Ki, mM
acetate

3.9 ± 0.6

malonate

3.0 ± 0.3

malate

52 ± 6

glycolate

28 ± 5

glyoxylate

15 ± 3

pyruvate

17 ± 3

a

Initial velocities were determined spectrophotometrically in succinate buffer, pH 4.0 using the coupled assay described in Material and Methods.
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Table 4

Comparison of results of FAAS and ICP-MS analyses of CsOxOx samples and specific activity.
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Sample

FAAS mol Mn/mol enz

ICP-MS mol Mn/mol enz

Activity U/mg

OxDC

1.60 ± 0.08

1.60 ± 0.01

N/A

CsOxOx (#1)

0.29 ± 0.05

0.22 ± 0.02

6.2 ± 0.3

CsOxOx (#2)

0.38 ± 0.04

0.34 ± 0.01

18.2 ± 0.6

CsOxOx (#3)

0.14 ± 0.03

0.18 ± 0.02

1.8 ± 0.1
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